Results 161 to 170 of about 113,350 (308)

Progression of albumin/creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) over 24 years in people with type 2 diabetes. Drivers, potential protectors and associated mortality

Diabetic Medicine, EarlyView.
Abstract Introduction The pathophysiology of chronic kidney disease (CKD) and type 2 diabetes (T2D) is multifactorial and associated with a plethora of underlying conditions and complications. Their link is reciprocal and understanding its nature, particularly over time, could improve the health of many.
Andreas Matheou, Orestis Zavlis, Steve White, Thomas McDonnell, Alexander Warner‐Levy, John Warner‐Levy, Loren Wilkins, Hellena Habte‐Asres, Abigail Lay, Liliana Shalamanova, Martin Whyte, Martin Gibson, Philip A. Kalra, Adrian Heald   +13 more
wiley   +1 more source

Effect of continuing versus stopping pre-stroke antihypertensive agents within 12 h on outcome after stroke: A subgroup analysis of the efficacy of nitric oxide in stroke (ENOS) trial. [PDF]

EClinicalMedicine, 2022
Woodhouse LJ, Appleton JP, Scutt P, Everton L, Wilkinson G, Caso V, Czlonkowska A, Gommans J, Krishnan K, Laska AC, Ntaios G, Ozturk S, Phillips S, Pocock S, Prasad K, Szatmari S, Wardlaw JM, Sprigg N, Bath PM, ENOS Investigators.   +19 more
europepmc   +1 more source

Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines

, 1986
Romeo Ciabatti, Giovanna Padova, E. BELLASIO, Giorgio Tarzia, A. Depaoli, F. BATTAGLIA, Mario Cellentani, Domenico Barone, E Baldoli   +8 more
openalex   +1 more source

Hypertension and its complications in a young man with autoimmune disease [PDF]

, 2017
Basile, Jan N., Batlle, Daniel C., Dhaun, Neeraj, Dominiczak, Anna F., Elijovich, Fernando, Jennings, Garry L.R., Laffer, Cheryl L., Miller-Hodges, Eve, Oliveras, Anna, Oparil, Suzanne   +9 more
core   +1 more source

Advancing Trauma Systems in the United States: Bridging Disparities Through State‐Level Legislation and a Health Systems Approach

Health Services Research, EarlyView.
Bilal Irfan, Zain Hashmi, Tatiana Ramos, Molly Jarman   +3 more
wiley   +1 more source

Use of sodium‐glucose cotransporter‐2 inhibitors among older adults with type 2 diabetes mellitus in British Columbia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Clinical guidelines recommend sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) for individuals with type 2 diabetes mellitus (T2DM) and established or high risk of cardiorenal disease. This study examined real‐world SGLT2i use patterns among older adults with T2DM in British Columbia, Canada.
Hanin Harbi, Gregory Carney, Colin Dormuth, Jacob Volmer Stidsen, Iliana Lega, Lisa M. McCarthy, Guillaume Grenet, Anshula Ambasta, Raha Eskandari, Anton Pottegård, Wade Thompson   +10 more
wiley   +1 more source

Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells. [PDF]

Front Cell Infect Microbiol, 2021
Pires de Souza GA, Osman IO, Le Bideau M, Baudoin JP, Jaafar R, Devaux C, La Scola B.   +6 more
europepmc   +1 more source

Hemodynamic and myocardial anti-stunning effects of a new antihypertensive agent. S-2150, in dogs

, 1995
Sadatoshi Kimoto, Masao Haitina, Eiichi Maisuura, Osamu Uno, Satoru Hirono, Molohiko Ueda, Kohji Yoshimura, Kazumi Iwaki   +7 more
openalex   +1 more source

Associations between steatotic liver disease subtypes and incident diabetes in young Korean adults: A nationwide cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The impact of steatotic liver disease (SLD) subtypes on incident type 2 diabetes remains unclear. We investigated the association of metabolic dysfunction‐associated steatotic liver disease (MASLD), MetALD (MASLD with moderate alcohol consumption), and alcohol‐related liver disease (ALD) with incident type 2 diabetes in Korean adults aged
Goh Eun Chung, Su Jong Yu, Jeayeon Park, Yoon Jun Kim, Jung‐Hwan Yoon, Kyungdo Han, Eun Ju Cho   +6 more
wiley   +1 more source

Fixed-dose combinations of lipid-lowering and antihypertensive agents: The way forward? [PDF]

J Clin Hypertens (Greenwich), 2020
Sofogianni A, Tziomalos K.
europepmc   +1 more source